Recherche
-
Signaling-specific inhibition of the CB1 receptor for cannabis use disorder: phase 1 and phase 2a randomized trials
(Nature Medicine. vol. 29, n° 6, pp. 1487-1499, 2023-06-01)Article de revueLibre accès -
Axo-axonic cells in neuropsychiatric disorders: a systematic review.
(Frontiers in Cellular Neuroscience. vol. 17, 2023-06-26)Article de revueLibre accès -
Functional heterogeneity of POMC neurons relies on mTORC1 signaling
(Cell Reports. vol. 37, n° 2, 2021-10-12)Article de revueLibre accès -
Microglia modulates hippocampal synaptic transmission and sleep duration along the light/dark cycle
(Glia, 2021)Article de revueLibre accès -
Insulin modulates emotional behavior through a serotonin-dependent mechanism
(Molecular Psychiatry, 2022-10-07)Article de revue -
Assessment of Translocator Protein Density, as Marker of Neuroinflammation, in Major Depressive Disorder: A Pilot, Multicenter, Comparative, Controlled, Brain PET Study (INFLADEP Study)
(Frontiers in Psychiatry. vol. 9, pp. 326, 2018)Article de revueLibre accès -
Cannabidiol for Oral Health: A New Promising Therapeutical Tool in Dentistry
(International Journal of Molecular Sciences. vol. 24, n° 11, 2023-06-02)Article de revueLibre accès -
Cannabis and exercise: Effects of Δ9-tetrahydrocannabinol on preference and motivation for wheel-running in mice
(Progress in Neuro-Psychopharmacology & Biological Psychiatry. vol. 105, 2021-03-08)Article de revueLibre accès -
Yin-Yang control of energy balance by lipids in the hypothalamus: The endocannabinoids vs bile acids case
(Biochimie, 2022)Article de revueLibre accès -
Identification of distinct pathological signatures induced by patient-derived α-synuclein structures in nonhuman primates
(Science Advances. vol. 6, n° 20, 2020-05-13)Article de revueLibre accès